Your browser doesn't support javascript.
loading
Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures.
Stone, Jennifer; Thompson, Deborah J; Dos Santos Silva, Isabel; Scott, Christopher; Tamimi, Rulla M; Lindstrom, Sara; Kraft, Peter; Hazra, Aditi; Li, Jingmei; Eriksson, Louise; Czene, Kamila; Hall, Per; Jensen, Matt; Cunningham, Julie; Olson, Janet E; Purrington, Kristen; Couch, Fergus J; Brown, Judith; Leyland, Jean; Warren, Ruth M L; Luben, Robert N; Khaw, Kay-Tee; Smith, Paula; Wareham, Nicholas J; Jud, Sebastian M; Heusinger, Katharina; Beckmann, Matthias W; Douglas, Julie A; Shah, Kaanan P; Chan, Heang-Ping; Helvie, Mark A; Le Marchand, Loic; Kolonel, Laurence N; Woolcott, Christy; Maskarinec, Gertraud; Haiman, Christopher; Giles, Graham G; Baglietto, Laura; Krishnan, Kavitha; Southey, Melissa C; Apicella, Carmel; Andrulis, Irene L; Knight, Julia A; Ursin, Giske; Alnaes, Grethe I Grenaker; Kristensen, Vessela N; Borresen-Dale, Anne-Lise; Gram, Inger Torhild; Bolla, Manjeet K; Wang, Qin.
Afiliação
  • Stone J; Centre for Genetic Origins of Health and Disease, University of Western Australia, Crawley, Western Australia, Australia.
  • Thompson DJ; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Dos Santos Silva I; Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Scott C; Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Tamimi RM; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Lindstrom S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts.
  • Kraft P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusett
  • Hazra A; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Human Genetics, Genome Institute of Singapore, Singapore, Singapore.
  • Eriksson L; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Jensen M; Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Cunningham J; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota.
  • Olson JE; Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
  • Purrington K; Department of Oncology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, Michigan.
  • Couch FJ; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota. Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
  • Brown J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Leyland J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Warren RM; Department of Radiology, University of Cambridge, Addenbrooke's NHS Foundation Trust, Cambridge, United Kingdom.
  • Luben RN; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Khaw KT; MRC Centre for Nutritional Epidemiology in Cancer Prevention and Survival (CNC), University of Cambridge, Cambridge, United Kingdom.
  • Smith P; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Wareham NJ; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Jud SM; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen-Nuremberg, Germany.
  • Heusinger K; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen-Nuremberg, Germany.
  • Beckmann MW; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen-Nuremberg, Germany.
  • Douglas JA; Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan.
  • Shah KP; Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan.
  • Chan HP; Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Helvie MA; Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Le Marchand L; University of Hawaii Cancer Center, Honolulu, Hawaii.
  • Kolonel LN; University of Hawaii Cancer Center, Honolulu, Hawaii.
  • Woolcott C; Department of Obstetrics and Genecology, IWK Health Centre, Halifax, Canada.
  • Maskarinec G; University of Hawaii Cancer Center, Honolulu, Hawaii.
  • Haiman C; Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Baglietto L; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia. Centre for Research in Epidemiology and Population Health, Gustave Roussy Institu
  • Krishnan K; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Southey MC; Department of Pathology, University of Melbourne, Melbourne, Australia.
  • Apicella C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Andrulis IL; Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Ursin G; Institute of Basic Medical Sciences, University of Oslo, Norway. Department of Preventive Medicine, University of Southern California, California.
  • Alnaes GI; Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway.
  • Kristensen VN; Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway.
  • Borresen-Dale AL; Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway.
  • Gram IT; Faculty of Health Sciences, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Wang Q; Faculty of Health Sciences, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Cancer Res ; 75(12): 2457-67, 2015 Jun 15.
Article em En | MEDLINE | ID: mdl-25862352
ABSTRACT
Mammographic density measures adjusted for age and body mass index (BMI) are heritable predictors of breast cancer risk, but few mammographic density-associated genetic variants have been identified. Using data for 10,727 women from two international consortia, we estimated associations between 77 common breast cancer susceptibility variants and absolute dense area, percent dense area and absolute nondense area adjusted for study, age, and BMI using mixed linear modeling. We found strong support for established associations between rs10995190 (in the region of ZNF365), rs2046210 (ESR1), and rs3817198 (LSP1) and adjusted absolute and percent dense areas (all P < 10(-5)). Of 41 recently discovered breast cancer susceptibility variants, associations were found between rs1432679 (EBF1), rs17817449 (MIR1972-2 FTO), rs12710696 (2p24.1), and rs3757318 (ESR1) and adjusted absolute and percent dense areas, respectively. There were associations between rs6001930 (MKL1) and both adjusted absolute dense and nondense areas, and between rs17356907 (NTN4) and adjusted absolute nondense area. Trends in all but two associations were consistent with those for breast cancer risk. Results suggested that 18% of breast cancer susceptibility variants were associated with at least one mammographic density measure. Genetic variants at multiple loci were associated with both breast cancer risk and the mammographic density measures. Further understanding of the underlying mechanisms at these loci could help identify etiologic pathways implicated in how mammographic density predicts breast cancer risk.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Glândulas Mamárias Humanas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Glândulas Mamárias Humanas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article